Portevo
US Companies
LLYNew York Stock Exchange

Eli Lilly (LLY) Financial Results

Eli Lilly's earnings release dates, analyst consensus, and share price reaction to past earnings — all in one place, in English.

Updated: October 11, 2026

Share Price
1,179.27 USD
+0.83%
Market Cap
1.05 T USD
Next Report
October 29, 2026
confirmed date
Earnings Beat
100%
out of 4 last quarters
Average Share Price Movement
6.95%
on the session after publication
P/E Ratio
39.59
Eli Lilly's Performance vs. ForecastsThe company beat analyst forecasts in 100% of the last 4 quarters.100%above forecasts
Percentage of quarters Eli Lilly beat analyst consensus — out of the last 4 reports.

When Eli Lilly Reports Earnings

The next Eli Lilly report is scheduled for October 29, 2026. The date is based on the company's announcement.

The expected earnings per share (EPS) is 8.09 USD. Analyst forecasts range from 4.65 to 11.31 USD. The market reacts not to the absolute earnings, but to the difference between the actual result and this forecast.

Expected revenue: 22.37 B USD.

Eli Lilly's Last Report: What the Numbers Showed

Eli Lilly's last reported quarter ended June 30, 2026. Revenue was $22.97 billion, and net income was $7.09 billion. Earnings per share reached $8.38 compared to analysts' forecasts of $6.58 — 27.27% above expectations. The share price changed by +6.84% on the first trading day after the release.

Revenue
$22.97 bn
for the quarter
Net income
$7.09 bn
for the quarter
EPS
8.38 USD
forecast 6.58
Surprise
+27.27%
vs. consensus
Share price after report
+6.84%
next trading day
Net margin
30.88%
net income to revenue

Insider Transactions: Eli Lilly

Who from the management board, supervisory board, US Congress, or government bought and sold shares of this company — based on official filings.

Insider Buys · 12 mo.
35
≈ $216M
Sales · 12 mo.
50
Unique individuals
23
in the last year
Last transaction
August 17, 2026
Latest transactionsForm 4, STOCK Act, OGE, MAR
Donald Trump
$15K–$50KJuly 23, 2026
Cathie Wood
Cathie Wood · buy LLY
Eli Lilly · ARK Investment Management fund
$77.5M June 30, 2026
Eli Lilly · Duquesne Family Office fund
$14.8M June 30, 2026
Patrik Jonsson · sell LLY
$7.6M August 17, 2026
Donald A Zakrowski · sell LLY
$2.4M August 10, 2026
Anat Hakim · sell LLY
Eli Lilly · indirectly
$6M August 7, 2026
Dan Newhouse
Dan Newhouse · sell LLY
Eli Lilly and · spouse
$1K–$15KJuly 10, 2026
Michael A. Rulli
$1K–$15KJuly 1, 2026
See insider faces on the chart in the app →

How the stock reacted to past earnings

The company beat analyst estimates in 100% of the last 4 quarters.

The average share price change on the day after earnings release is 6.95% — regardless of direction. The largest move was 13.17%. This number says more about the risk of holding a position through an earnings report than the earnings forecast itself.

Eli Lilly Share Price Reaction After EarningsBar chart: Eli Lilly share price change on the day after the last 4 earnings releases. Increased after 4 of them, decreased after 0. Largest movement: 13.17%.+6.06%X 25+1.73%Feb 26+13.17%Q26+6.84%Aug 26
Eli Lilly share price change on the day of the report release. Green bar indicates an increase, red indicates a decrease.
EPS Forecast vs. Actual — Eli LillyThis chart compares Eli Lilly's actual EPS to analyst forecasts over the last 4 quarters. The company beat estimates in 4 of those quarters.5.897.02Q3 256.917.54Q4 256.798.55Q1 266.588.38Q2 26analyst forecastCompany earnings
Eli Lilly Earnings Per Share: Analyst Forecasts and Actual Results, in USD.
Eli Lilly's quarterly results — forecast, actual, and share price performance on the day of the announcement. EPS values in USD.
QuarterRelease dateEPS estimateActual EPSSurpriseShare price reaction
June 30, 2026August 5, 20266.588.38+27.27%+6.84%
March 31, 2026April 30, 20266.798.55+25.90%+13.17%
December 31, 2025February 4, 20266.917.54+9.14%+1.73%
September 30, 2025October 30, 20255.897.02+19.15%+6.06%

How much this company's stock moves after earnings

Eli Lilly's share price changes by an average of 6.95% on the first trading day after earnings announcements, based on the last 4 reports, regardless of direction. This ranks 68 out of 180 companies for which we calculate this statistic.

Analyst forecasts for upcoming periods

The consensus is the average of many analysts' forecasts. The more analysts behind a number, the less likely it is to be a single error—but forecast agreement is never a guarantee of the actual result.

Eli Lilly Forecasts — EPS values in USD.
PeriodEPS estimateEPS a year agoChangeRevenue forecastAnalysts
Current quarter8.097.02+15.31%$22.37 bn17
Next quarter10.057.54+33.35%$23.39 bn17
Current year35.7724.21+47.76%$88.50 bn27
Next year47.6435.77+33.16%$102.35 bn27

Revenue and margins quarter by quarter

Margin shows how much of sales a company retains. Rising revenue with shrinking margins means growth is coming at the expense of profitability—and that's usually more interesting than sales growth alone.

Eli Lilly Revenue and MarginThis bar chart shows Eli Lilly's quarterly revenue over the last 5 quarters; revenue is growing, and the overlaid line shows net margin.Q2 25Q3 25Q4 25Q1 26Q2 2636.39%31.72%34.41%37.36%30.88%Quarterly revenueNet margin
Eli Lilly's quarterly revenue in USD and net margin for the same quarter.
Eli Lilly Quarterly Income Statement.
QuarterRevenueGross marginOperating marginNet margin
June 30, 2026$22.97 bn85.78%54.22%30.88%
March 31, 2026$19.80 bn81.93%49.39%37.36%
December 31, 2025$19.29 bn82.52%46.59%34.41%
September 30, 2025$17.60 bn82.91%47.65%31.72%
June 30, 2025$15.56 bn84.27%45.13%36.39%

Eli Lilly Dividend

The last ex-dividend date was August 14, 2026. The date of the next payment is not yet known — it depends on the resolution of the general meeting, and Yahoo only publishes the date after it has been announced.

Dividend Yield
0.59%
from the last payment
Per Share
6.92 USD
annually
Payout Ratio
21.69%
portion of profit returned to shareholders
Ex-dividend date
August 14, 2026
last known

Who Reports in the Coming Weeks

Dates from the Portevo calendar — companies in the same industry are listed first, as their earnings often move the share prices of their peers even before their own reports.

About Eli Lilly

Eli Lilly and Company is listed on the New York Stock Exchange under the ticker LLY and is headquartered in the United States. The company belongs to the healthcare sector (industry: Drug Manufacturers - General).

  • Ticker: LLY
  • Exchange: New York Stock Exchange
  • Trading Currency: USD
  • Sector: healthcare
  • Number of Analysts Providing Estimates: 29
  • 52-Week Range: 783.85 – 1,292.65
  • Company Website: https://www.lilly.com

Frequently Asked Questions

When does Eli Lilly report earnings?

The next report is scheduled for October 29, 2026.

What were Eli Lilly's results last quarter?

For the quarter ended June 30, 2026: revenue 22.97 billion USD, net income 7.09 billion USD, EPS 8.38 USD. This was +27.27% above analyst forecasts.

What is Eli Lilly's stock ticker?

LLY — on the New York Stock Exchange. You may also see LLY on quote services.

What is the EPS forecast for Eli Lilly?

The analyst consensus for the upcoming quarter is $8.09 per share. Individual forecasts range from $4.65 to $11.31.

How much does Eli Lilly's stock price usually change after earnings?

On average, 6.95% in the session after publication, counting both directions. The largest recorded movement was 13.17%.

Does Eli Lilly usually beat analyst forecasts?

In the last 4 quarters, results exceeded forecasts in 100% of cases. History does not predict the next report, but it shows how cautiously analysts approach this company.

Where can I find Eli Lilly's financial results in English?

On Portevo — the earnings calendar, analyst forecasts, surprise history, and share price reactions are available for free and without an account.

Other companies in the healthcare sector

A company's earnings are most informative when compared to competitors in the same industry — this shows whether a weak quarter was a company-specific issue or a market-wide trend.

Related

Track Eli Lilly on Portevo

The company page in the app includes a price chart, indicators, and industry comparisons. Add a company to your watchlist, and its report will be highlighted in the earnings calendar—along with the rest of your portfolio.

Portevo is not an investment advisor. The data and analyses are for informational and educational purposes only and do not constitute a recommendation or an offer to buy or sell financial instruments. Quotes are from external providers and may be delayed. You make investment decisions at your own risk.

Portevo App

Your entire portfolio, company earnings, and insider trades in one place

Upload your XTB report or add companies manually — Portevo will calculate your net profit after costs, show you the earnings dates for your companies, and display insider faces on charts.

  • Portfolio with Net Profit After Costs
  • Earnings Calendar for Your Companies
  • Pelosi, Trump, and CEO Trades on a Chart
  • Works in Browser and on iPhone

No credit card required. A demo portfolio is available immediately; create your own by uploading a report.

Portevo Portfolio: Value, Net Performance, and ChartCompany Earnings Calendar in the Portevo AppETF Fact Sheet with Quotes in PortevoTransaction History and Portfolio Tracking in Portevo
Portevo — free portfolio, earnings, and insider tradesOpen App